Antibodies binding AXL
US10500276B2 · kind B2 · utility
2Cited by
1References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2019 |
| Grant date | Dec 10, 2019 |
| Priority date | — |
| Expiry date | Feb 7, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-AXL antibodies, immunoconjugates, compositions and method of treatment of cancer with such anti-AXL antibodies, immunoconjugates, or compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.